# A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.

> **NCT07496177** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences** · enrollment: 75 (estimated)

## Conditions studied

- T2DM
- CKD

## Interventions

- **DRUG:** HTD1801
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT07496177
- **Lead sponsor:** Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07496177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07496177, "A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07496177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*